Evaluation of the efficacy of oral nano‐silymarin formulation in hospitalized patients with COVID‐19: A double‐blind placebo‐controlled clinical trial-Reference-Cited by-同舟云学术

Evaluation of the efficacy of oral nano‐silymarin formulation in hospitalized patients with COVID‐19: A double‐blind placebo‐controlled clinical trial

Published:2022-07-20 Issue:10 Volume:36 Page:3924-3931
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Aryan Hossein¹,Farahani Ramin Hamidi²,Chamanara Mohsen³⁴,Elyasi Sepideh⁵^ORCID,Jaafari Mahmoud Reza⁶⁷,Haddad Mahboubeh⁷,Sani Ashraf Tavanaee⁸,Ardalan Mohamed Afshar⁹,Mosaed Reza¹⁰^ORCID

Affiliation:

1. Department of Anesthesiology and Intensive Care Aja University of Medical Sciences Tehran Iran

2. Infectious Disease Research Center AJA University of Medical Sciences Tehran Iran

3. Toxicology Research Center Aja University of Medical Sciences Tehran Iran

4. Department of Pharmacology, School of Medicine Aja University of Medical Sciences Tehran Iran

5. Department of Clinical Pharmacy School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

6. Nanotechnology Research Center Pharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

7. Department of Pharmaceutical Nanotechnology School of Pharmacy, Mashhad University of Medical Sciences Mashhad Iran

8. Department of Infectious Diseases and Tropical medicine Faculty of medicine, Mashhad University of medical sciences Mashhad Iran

9. Faculty of Medicine Mashhad University of Medical Sciences Mashhad Mashhad Iran

10. Internal Medicine Department School of Medicine, AJA University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7537

Reference35 articles.

1. Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinical trial

2. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19

3. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

4. The psychological impact of quarantine and how to reduce it: rapid review of the evidence

5. Patterns of deterioration in moderate patients with COVID‐19: A multi‐center, retrospective cohort study;Chen S.‐L.;Frontiers in Medicine,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents;Expert Opinion on Pharmacotherapy;2024-04-12

2. Impacts of Supplementation with Silymarin on Cardiovascular Risk Factors: A Systematic Review and Dose–Response Meta-Analysis;Antioxidants;2024-03-24

3. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose–response meta‐analysis;Phytotherapy Research;2024-03-12

4. Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review;Cureus;2023-10-24

5. Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies;Pharmaceuticals;2023-10-17